DELLA TORRE, EMANUEL
 Distribuzione geografica
Continente #
EU - Europa 4.771
AS - Asia 4.122
NA - Nord America 2.697
SA - Sud America 1.133
AF - Africa 94
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.859
Nazione #
US - Stati Uniti d'America 2.553
RU - Federazione Russa 2.520
SG - Singapore 1.393
CN - Cina 1.379
BR - Brasile 923
IT - Italia 862
HK - Hong Kong 523
SE - Svezia 517
VN - Vietnam 429
FR - Francia 215
DE - Germania 166
GB - Regno Unito 132
FI - Finlandia 94
AR - Argentina 75
IN - India 70
CA - Canada 61
MX - Messico 58
NL - Olanda 55
BD - Bangladesh 47
ES - Italia 39
ID - Indonesia 39
AT - Austria 37
PL - Polonia 37
TR - Turchia 36
JP - Giappone 35
ZA - Sudafrica 35
AU - Australia 33
IQ - Iraq 32
EC - Ecuador 31
CO - Colombia 26
PY - Paraguay 25
PK - Pakistan 22
IE - Irlanda 19
UA - Ucraina 19
PE - Perù 16
CL - Cile 15
VE - Venezuela 15
MA - Marocco 13
EG - Egitto 12
PH - Filippine 11
TN - Tunisia 11
UZ - Uzbekistan 11
IL - Israele 10
IR - Iran 10
SA - Arabia Saudita 10
JO - Giordania 9
KE - Kenya 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
CH - Svizzera 8
LT - Lituania 8
NZ - Nuova Zelanda 7
DZ - Algeria 6
HN - Honduras 6
NP - Nepal 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
KZ - Kazakistan 5
RO - Romania 5
AL - Albania 4
LB - Libano 4
LV - Lettonia 4
PT - Portogallo 4
UY - Uruguay 4
BH - Bahrain 3
CY - Cipro 3
CZ - Repubblica Ceca 3
GR - Grecia 3
HU - Ungheria 3
MD - Moldavia 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
EU - Europa 2
HR - Croazia 2
JM - Giamaica 2
KR - Corea 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 12.855
Città #
Singapore 603
Moscow 526
Hong Kong 518
Dallas 444
Ashburn 336
Shanghai 322
Beijing 257
San Jose 243
Hefei 199
Lawrence 183
Princeton 183
Lauterbourg 179
New York 169
Milan 154
Ho Chi Minh City 153
Hanoi 94
São Paulo 88
Helsinki 78
Los Angeles 69
Rome 65
Boardman 52
Munich 45
Rio de Janeiro 35
Orem 33
Nuremberg 32
Warsaw 32
Santa Clara 31
London 30
Denver 29
Tokyo 25
Belo Horizonte 24
Guangzhou 21
Poplar 21
Seattle 20
Brooklyn 19
Dublin 19
Frankfurt am Main 19
Mexico City 19
Montreal 19
Turin 19
Atlanta 18
Chennai 18
Cagliari 17
Da Nang 16
Haiphong 16
Phoenix 16
Toronto 16
Vienna 16
Stockholm 15
Baghdad 14
Bologna 14
Brasília 14
Cesano Boscone 14
Florence 14
Johannesburg 14
Ankara 13
Genoa 13
Houston 13
Manaus 13
Amsterdam 12
Boston 12
Mapello 12
Naples 12
Quito 12
Bari 11
Porto Alegre 11
Turku 11
Biên Hòa 10
Curitiba 10
Guarulhos 10
Pavia 10
Pescara 10
Rovigo 10
San Francisco 10
Tashkent 10
Wollongong 10
Xi'an 10
Asunción 9
Bergamo 9
Cape Town 9
Galliate 9
Guayaquil 9
Jakarta 9
Jiaxing 9
Melbourne 9
Nairobi 9
Pune 9
Salvador 9
Amman 8
Barnet 8
Basingstoke 8
Brisbane 8
Campinas 8
Council Bluffs 8
Falkenstein 8
Manchester 8
Mumbai 8
Sundbyberg 8
Thái Bình 8
Vaprio d'Adda 8
Totale 6.079
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 360
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 225
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 164
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 147
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 145
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 138
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 133
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 123
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 114
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 113
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 110
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 108
Advances in the diagnosis and management of IgG4 related disease. 107
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 106
Analisi delle sottopopolazioni T linfocitarie su sangue periferico dei pazienti affetti da malattia IgG4 correlata: aspetti patogenetici e risposta alla terapia con rituximab 105
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 103
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 102
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 99
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 99
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 99
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 98
Urgent manifestations of immunoglobulin G4-related disease 96
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 96
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 95
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 93
ALLERGIC PROFILE AND ALLERGENSPECIFIC IMMUNOTHERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A SINGLE CENTER OBSERVATIONAL STUDY 93
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 92
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 92
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 91
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 91
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 90
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 89
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 87
ANTIAPOPTOTIC AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN 7 IN AN EX VIVO MODEL OF HUMAN LYMPHOID TISSUE 87
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 87
"How I manage" IgG4-Related Disease 86
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 86
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 85
B cells orchestrate tissue fibrosis in IgG4-Related Disease 85
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 84
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 84
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 83
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 83
IgG4-Related Midline Destructive Lesion: Expanding the spectrum of organ involvement in IgG4-related disease 82
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 80
25. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study. 78
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 77
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 77
Atopia e malattia IgG4-correlata: relazione casuale o causale? 77
Artrite reumatoide. Dottore mi spieghi meglio 76
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 76
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 74
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 74
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 73
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 72
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 72
Salivary Gland Disease in IgG4-Related Disease is Associated with Allergic Conditions 72
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 71
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 71
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 70
Lymphadenopathy in the rheumatology practice: a pragmatic approach 69
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 69
Systemic lupus erythematosus and COVID-19: what we know so far 68
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 68
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 68
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 66
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 66
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 66
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 66
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. 66
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS 66
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 65
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 64
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 64
EFFICACY OF LONG-TERM TREATMENT WITH BIOLOGIC AGENTS IN REFRACTORY ADULT ONSET STILL’S DISEASE: A SINGLE CENTRE EXPERIENCE ON 16 PATIENTS 63
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study 63
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 62
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 61
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 61
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 60
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 60
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 60
IgG4-Related diseases 60
COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients 59
Malattia sistemica e colangiopatia IgG4-relata 59
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 58
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 58
Clonal Expansion of a Speci c Subset of Cytotoxic CD4+T Cells and Tissue Apoptosis in Patients with IgG4-related Disease 57
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. 57
Optimal management of DRESS syndrome in course of infectious endocarditis. 57
Malattie autoinfiammatorie e altre malattie immunomediate a patogenesi incerta 57
Side effects from polydioxanone 56
Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis 55
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 55
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 55
Cannabaceae pollen in the atmosphere of Brianza, Northen Italy 55
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. 55
Totale 8.748
Categoria #
all - tutte 77.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 1 3 1
2021/2022348 1 0 151 33 6 22 14 23 34 21 23 20
2022/20231.129 455 213 66 8 32 115 62 57 59 14 22 26
2023/2024920 30 62 81 82 49 167 42 89 5 42 92 179
2024/20252.858 351 84 81 76 97 222 352 300 550 329 177 239
2025/20267.823 631 790 689 1.061 631 258 680 560 2.180 343 0 0
Totale 13.127